Kimia Biosciences (BOM:530313) Scaled Net Operating Assets: (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
23 GF Score
Price ₹31.00
View Full Analysis

What is Kimia Biosciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kimia Biosciences's operating assets for the quarter that ended in . 20 was ₹ Mil. Kimia Biosciences's operating liabilities for the quarter that ended in . 20 was ₹ Mil. Kimia Biosciences's Total Assets for the quarter that ended in . 20 was ₹ Mil. Therefore, Kimia Biosciences's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .

Kimia Biosciences Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Scaled Net Operating Assets Chart

Kimia Biosciences Annual Data
Trend
Scaled Net Operating Assets

Kimia Biosciences Semi-Annual Data
Scaled Net Operating Assets

BOM:530313 vs ZTS: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Scaled Net Operating Assets falls into.


BOM:530313
23GF Score
Kimia Biosciences Ltd BOM:530313
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kimia Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(A: . 20 )
=(Operating Assets (A: . 20 )-Operating Liabilities (A: . 20 ))/Total Assets (A: . 20 )
=(-)/
=

where

Operating Assets(A: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Operating Liabilities(A: . 20 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
= - -
=

Kimia Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(Q: . 20 )
=(Operating Assets (Q: . 20 )-Operating Liabilities (Q: . 20 ))/Total Assets (Q: . 20 )
=(-)/
=

where

Operating Assets(Q: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Operating Liabilities(Q: . 20 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
= - -
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
23GF Score

Get the complete analysis for BOM:530313

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.00
Price